JP2022554019A5 - - Google Patents
Info
- Publication number
- JP2022554019A5 JP2022554019A5 JP2022525889A JP2022525889A JP2022554019A5 JP 2022554019 A5 JP2022554019 A5 JP 2022554019A5 JP 2022525889 A JP2022525889 A JP 2022525889A JP 2022525889 A JP2022525889 A JP 2022525889A JP 2022554019 A5 JP2022554019 A5 JP 2022554019A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- free base
- disease
- disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962932652P | 2019-11-08 | 2019-11-08 | |
| US62/932,652 | 2019-11-08 | ||
| PCT/US2020/059287 WO2021092292A1 (en) | 2019-11-08 | 2020-11-06 | FREE BASE CRYSTALLINE FORM OF A COMPLEMENT COMPONENT C5a RECEPTOR |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022554019A JP2022554019A (ja) | 2022-12-27 |
| JP2022554019A5 true JP2022554019A5 (https=) | 2023-11-09 |
Family
ID=75846182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022525889A Withdrawn JP2022554019A (ja) | 2019-11-08 | 2020-11-06 | 補体成分Ｃ５ａ受容体の遊離塩基結晶形態 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US11026935B2 (https=) |
| EP (1) | EP4054577A4 (https=) |
| JP (1) | JP2022554019A (https=) |
| KR (1) | KR20220098179A (https=) |
| CN (1) | CN114641289A (https=) |
| AU (1) | AU2020378061A1 (https=) |
| BR (1) | BR112022007488A2 (https=) |
| CA (1) | CA3155596A1 (https=) |
| CL (1) | CL2022001173A1 (https=) |
| IL (1) | IL292317A (https=) |
| MX (1) | MX2022005403A (https=) |
| WO (1) | WO2021092292A1 (https=) |
| ZA (1) | ZA202305622B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114867473A (zh) | 2019-11-08 | 2022-08-05 | 凯莫森特里克斯股份有限公司 | 补体成分c5a受体的盐形式 |
| US11603356B2 (en) | 2019-11-08 | 2023-03-14 | Chemocentryx, Inc. | Amorphous form of a complement component C5a receptor |
| JP2022554019A (ja) * | 2019-11-08 | 2022-12-27 | ケモセントリックス，インコーポレイティド | 補体成分Ｃ５ａ受容体の遊離塩基結晶形態 |
| WO2022078269A1 (zh) * | 2020-10-16 | 2022-04-21 | 苏州科睿思制药有限公司 | Avacopan的晶型及其制备方法和用途 |
| JP7839157B2 (ja) * | 2020-10-28 | 2026-04-01 | ケモセントリックス， インコーポレイテッド | 化膿性汗腺炎を処置する方法 |
| EP4137133A1 (en) | 2021-08-19 | 2023-02-22 | Sandoz AG | Crystalline form of avacopan |
| WO2022263263A1 (en) | 2021-06-16 | 2022-12-22 | Sandoz Ag | Crystalline form of avacopan |
| US20260027049A1 (en) | 2024-07-23 | 2026-01-29 | Amgen Inc. | Avacopan formulations |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4996467B2 (ja) * | 2004-09-27 | 2012-08-08 | アカディア ファーマシューティカルズ インコーポレイテッド | Ｎ−（４−フルオロベンジル）−ｎ−（１−メチルピペリジン−４−イル）−ｎ’−（４−（２−メチルプロピルオキシ）フェニルメチル）カルバミド、並びにその酒石酸塩及び結晶形態の合成 |
| RS54998B1 (sr) | 2008-12-22 | 2016-11-30 | Chemocentryx Inc | Antagonisti c5ar |
| US20110275639A1 (en) | 2008-12-22 | 2011-11-10 | Chemocentryx, Inc. | C5aR ANTAGONISTS |
| RS56332B1 (sr) | 2010-06-24 | 2017-12-29 | Chemocentryx Inc | Antagonisti c5ar |
| DK3200791T3 (da) | 2014-09-29 | 2020-05-25 | Chemocentryx Inc | Fremgangsmåder og mellemprodukter i fremstilling af C5AR- antagonister |
| CN114867473A (zh) * | 2019-11-08 | 2022-08-05 | 凯莫森特里克斯股份有限公司 | 补体成分c5a受体的盐形式 |
| JP2022554019A (ja) * | 2019-11-08 | 2022-12-27 | ケモセントリックス，インコーポレイティド | 補体成分Ｃ５ａ受容体の遊離塩基結晶形態 |
| WO2022078269A1 (zh) * | 2020-10-16 | 2022-04-21 | 苏州科睿思制药有限公司 | Avacopan的晶型及其制备方法和用途 |
-
2020
- 2020-11-06 JP JP2022525889A patent/JP2022554019A/ja not_active Withdrawn
- 2020-11-06 KR KR1020227018961A patent/KR20220098179A/ko not_active Withdrawn
- 2020-11-06 WO PCT/US2020/059287 patent/WO2021092292A1/en not_active Ceased
- 2020-11-06 MX MX2022005403A patent/MX2022005403A/es unknown
- 2020-11-06 CA CA3155596A patent/CA3155596A1/en active Pending
- 2020-11-06 EP EP20884944.8A patent/EP4054577A4/en not_active Withdrawn
- 2020-11-06 CN CN202080077446.8A patent/CN114641289A/zh active Pending
- 2020-11-06 AU AU2020378061A patent/AU2020378061A1/en not_active Abandoned
- 2020-11-06 IL IL292317A patent/IL292317A/en unknown
- 2020-11-06 BR BR112022007488A patent/BR112022007488A2/pt not_active IP Right Cessation
- 2020-11-06 US US17/091,019 patent/US11026935B2/en active Active
-
2021
- 2021-05-04 US US17/307,865 patent/US20220096453A1/en not_active Abandoned
-
2022
- 2022-05-04 CL CL2022001173A patent/CL2022001173A1/es unknown
-
2023
- 2023-04-24 US US18/305,611 patent/US20230381167A1/en not_active Abandoned
- 2023-05-25 ZA ZA2023/05622A patent/ZA202305622B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022554019A5 (https=) | ||
| JP2023501789A5 (https=) | ||
| TWI344957B (en) | Chemical process and intermediates | |
| JP2000500154A (ja) | モルホリン誘導体及び治療薬としてのそれらの使用 | |
| JP2023116503A5 (https=) | ||
| AU656379B2 (en) | Crystalline oxathiolane derivatives | |
| JP2021181446A5 (https=) | ||
| JPH10511973A (ja) | タキキニンアンタゴニスト活性を有するピペリジン誘導体 | |
| EA011164B1 (ru) | Производные пиримидина для профилактики вич-инфекции | |
| JPH11502810A (ja) | ニューロキニンアンタゴニストとしての３−ベンジルアミノ−２−フェニルピペリジン | |
| JP2007525457A (ja) | 置換１，４−ジアゼピン及びその使用 | |
| TW201043623A (en) | Crystalline tripeptide epoxy ketone protease inhibitors | |
| JP2010514807A5 (https=) | ||
| JP2022510304A5 (https=) | ||
| JP2023139178A (ja) | 癌の組合せ治療 | |
| JP2021518853A (ja) | ドーパミンｄ１受容体ポジティブ調節因子としてのピラゾテトラヒドロイソキノリン誘導体 | |
| TW202430149A (zh) | Ｎ，ｎ－二甲基色胺之結晶形式及其使用方法 | |
| JP2010534669A5 (https=) | ||
| CN100422139C (zh) | 氨基链烷醇衍生物 | |
| JPH07505402A (ja) | ５−ｈｔ↓１様アゴニストとしてのインドール誘導体 | |
| JP2024001040A5 (https=) | ||
| Edrees | Relapsing polychondritis: a description of a case and review article | |
| CN102131803A (zh) | (1r，2s，3r)-1-(2-(异噁唑-3-基)-1h-咪唑-4-基)丁烷-1，2，3，4-四醇的固体形式及其使用方法 | |
| JPS59134756A (ja) | ジアルキルアミノアルコキシベンジルアルコ−ル誘導体 | |
| JP2024520897A5 (https=) |